1 |
陶 春,童 瑜,王 旗,等.耐碳青霉烯类鲍曼不动杆菌颅内感染多途径应用多黏菌素类药物治疗的病例分析[J].医药导报,2024,43(10): 1583-1588.
|
2 |
Tamma PD,Aitken SL,Bonomo RA,et al.Infectious diseases society of america guidance on the treatment of ampc β-lactamaseproducing enterobacterales,carbapenem-resistant acinetobacter baumannii,and Stenotrophomonas maltophilia Infections[J].Clin Infect Dis,2022,74(12): 2089-2114.
|
3 |
庞茜茜,刘 斐,蒲洁琨,等.两种联合用药方案治疗耐碳青霉烯类鲍曼不动杆菌肺炎的效果及对炎症反应的影响[J].中国医院用药评价与分析,2024,24(2): 176-179.
|
4 |
Zhang DF,Zhang ZF,Li PD,et al.Characterization of carbapenemresistant Acinetobacter baumannii ST540 and Klebsiella pneumoniae ST2237 isolates in a pneumonia case from China[J].J Appl Microbiol,2022,133(3): 1434-1445.
|
5 |
Franzone JP,Mackow NA,van Duin D.Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii[J].Curr Opin Infect Dis,2024,37(2): 137-143.
|
6 |
王月华,鞠晓红.棘阿米巴感染治疗药物的研究进展[J].医药导报,2023,42(9): 1363-1367.
|
7 |
吴 凡,王保贵,胡 文,等.多西环素联合左氧氟沙星对耐药肺炎克雷伯菌的体内外抗菌活性研究[J].中国新药杂志,2023,32(23): 2425-2433.
|
8 |
El-Ghali A,Kunz Coyne AJ,et al.Sulbactam-durlobactam:A novel β-lactam-β-lactamase inhibitor combination targeting carbapenemresistant Acinetobacter baumannii infections[J].Pharmacotherapy,2023,43(6): 502-513.
|
9 |
Wu L,Li X,Li Z,et al.HtrA serine proteases in cancers: A target of interest for cancer therapy[J].Biomed Pharmacother,2021,139: 111603.
|
10 |
杨 阳,任田田,徐 鹏.耐碳青霉烯类肺炎克雷伯菌感染治疗效果影响因素分析及预测模型建立[J/OL].现代疾病预防控制,2024,35(10): 726-731.
|
11 |
黄冬梅,刘 军,李福祥,等.四川省二级综合医院CRAB 感染发生的相关危险因素分析[J/CD].中华肺部疾病杂志(电子版),2020,13(3): 355-359.
|
12 |
晁晓峰,冯倚帆,黄天宁,等.颅脑术后继发颅内多重耐药鲍曼不动杆菌感染的危险因素[J].中国临床神经外科杂志,2022,27(6): 471-473.
|
13 |
段 炜,范沁林,刘 勇.替加环素对NICU 碳青霉烯耐药菌致院内获得性肺炎抗感染疗效的回顾性分析[J/CD].中华肺部疾病杂志(电子版),2019,12(3): 315-320.
|
14 |
Zha L,Zhang X,Cheng Y,et al.Intravenous Polymyxin b as adjunctive therapy to high-dose tigecycline for the treatment of nosocomial pneumonia due to carbapenem-resistant acinetobacter baumannii and klebsiella pneumoniae: a propensity score-matched cohort study[J].Antibiotics (Basel),2023,12(2): 273.
|
15 |
黄育波,周宇麒,郑文争,等.多重耐药鲍曼不动杆菌外排泵与外膜蛋白表达水平分析[J].实用医学杂志,2023,39(16):2122-2129.
|
16 |
Deng Y,Chen L,Yue M,et al.Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia[J].BMC Infect Dis,2022,22(1): 795.
|
17 |
罗 丹,李玉良,翁邦碧,等.鲍曼不动杆菌快速表型药敏检测方法的建立和初步应用[J].第三军医大学学报,2021,43(18): 1775-1782.
|
18 |
王保贵,王娜娜,周思绪,等.多西环素联合利福平对耐碳青霉烯类肺炎克雷伯菌体内外抗菌活性[J].中国抗生素杂志,2023,48(10): 1183-1191.
|
19 |
Sitovs A,Sartini I,Giorgi M.Levofloxacin in veterinary medicine:a literature review[J].Res Vet Sci,2021,137: 111-126.
|
20 |
Aslam HM,Sohail A,Shahid A,et al.Levofloxacin induces erythrocyte contraction leading to red cell death[J].Drug Target Insights,2024,18: 78-83.
|
21 |
陈苏维,艾雪言,刘 晔,等.盘基网柄菌基网柄菌HtrA2 基因的克隆与生物信息学分析[J].安康学院学报,2022,34(4):123-128.
|
22 |
Feng L,Li Z,Xiong Y,et al.HtrA2 independently predicts poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma[J].J Oncol,2023,4067418.
|
23 |
Tian Z,Zhao J,Wang Y.The prognostic value of TPM1-4 in hepatocellular carcinoma[J].Cancer Med,2022,11(2): 433-446.
|
24 |
柴 媛,王俊瑞,英 兰,等.BALB/c 大鼠多重耐药鲍曼不动杆菌肺部感染模型的建立和评估[J].微生物与感染,2022,17(2): 71-80.
|
25 |
张 阳,焦雨佼,巩翠珂,等.慢阻肺患者鲍曼不动杆菌感染肺泡巨噬细胞凋亡机制的研究[J].中国病原生物学杂志,2022,17(9): 1082-1085.
|
26 |
陶兴茹,段彦彦,董丽丽,等.左氧氟沙星和多西环素治疗儿童难治性支原体肺炎的安全性和有效性分析[J].中南药学,2021,19(5): 1025-1028.
|
27 |
Xu Z,Lin J,Xie Y,et al.HtrA2 is required for inflammatory responses in BMDMs via controlling TRAF2 stability in collageninduced arthritis[J].Mol Immunol,2021,129: 78-85.
|
28 |
何谷良,吴 涛,卢芳国,等.麻杏石甘汤对流感病毒肺部感染模型肺组织TLR2/4-MyD88 信号通路蛋白表达的影响[J].中华中医药杂志,2022,37(1): 435-440.
|
29 |
Gong Z,Zhang J,Zhang S,et al.TLR2,TLR4,and NLRP3 mediated the balance between host immune-driven resistance and tolerance in Staphylococcus aureus-infected mice [ J].Microb Pathog,2022,169: 105671.
|
30 |
严宝飞,戴仕林,刘圣金,等.黄芩汤对非酒精性脂肪肝炎大鼠的作用及机制研究[J].中国医院药学杂志,2022,42(10):1009-1014.
|